American businesses are increasingly using their lobbying muscle as a substitute for innovation, giving cash and urging legislation aimed at stifling rival companies and technologies, writes James Allworth. "Given how hard it can be to survive a disruptive challenge, and how effective lobbying has proven in stopping it, it's no wonder that incumbent firms take this route so often," Allworth writes.